Translational and Clinical Science Community

Back to discussions
Expand all | Collapse all

OSD on AI Approaches for Biomarker Discovery and Precision Medicine_24Jun2026

  • 1.  OSD on AI Approaches for Biomarker Discovery and Precision Medicine_24Jun2026

    Community Leadership
    Posted an hour ago

    Please join us for an Open Scientific Discussion (OSD) hosted by the AAPS Translational and Clinical Sciences Community on June 24, 12 pm – 1 pm EST on the following topic:

     

    AI for clinical biomarker discovery

    ·        Deep Learning approaches for clinical Biomarker Discovery

    ·        Contrastive learning to discover Predictive Biomarkers

    ·        Leveraging clinicogenomic data to improve patient stratification

    AI/ML in toxicity prediction

    ·        Machine learning and multi-omics integration for chemical toxicity assessment

    ·        Connectivity between cellular perturbations and organism-level adverse outcomes

    ·        Image-based cell profiling and reference atlases for mode-of-action inference

    Moderator:

    ·        Joost Groot

    Panelists:

    ·        Etai Jacob - Head of Applied Data Science & AI for Oncology R&D, AstraZeneca https://www.linkedin.com/in/etaijacob/

    ·        Jess Ewald - Group Leader, EMBL https://www.linkedin.com/in/jess-ewald-17140072/   

    Organizers:  

    ·        Jurre Kamphorst (Astrazeneca), Iris Qiu (Novartis), Joost Groot (Applied SysBio), Karen Quadrini (Prothena Biosciences), and Carmen Fernández-Metzler (PharmaCadence) 

    When:  Wednesday, June 24, 2026 at 12 pm – 1 pm EST    We start at 12:00 EST sharp.  

    Where:  Free registration at Advanced ML/AI Approaches for Biomarker Research and Precision Medicine

    This OSD is open to all the scientific community and hosted through Science 360.  The link above will take AAPS members directly to the OSD page.  For non-members, the link will allow you to create a free account in order to join the OSD.  There will be the possibility to submit questions.

    Please feel free to share with everyone who may be interested in this topic, especially your biomarker and omics focused colleagues.

      

    Thanks,

    On Behalf of The AAPS Translational and Clinical Biosciences Community Programming and Science Exchange Activity Team



    ------------------------------
    Carmen Fernandez-Metzler Ph.D.
    President
    PharmaCadence Analytical Services, LLC
    Hatfield PA
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------